BRD2 and polycystic ovary syndrome: In patients with PCOS, GCs frequently exhibit altered responsiveness to luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which further exacerbates dysfunction in follicle development and ovulation [46].